A medicine used to treat depressive illness. A demonstrated treatment effect does not, by itself, identify the biochemical abnormality that originally caused the illness.
An antidepressant class whose principal initial pharmacological action inhibits serotonin transport back into presynaptic cells. Initial transporter inhibition and subsequent clinical improvement need not have the same time course.
A selective serotonin reuptake inhibitor studied in several mental disorders. A favorable treatment response does not by itself establish that a simple serotonin deficiency caused the condition.[ref]
A randomized controlled trial of medication and cognitive-behavioral therapy for hypochondriasis by Brian A. Fallon and others. 2017; randomized pharmacotherapy comparison and qualified efficacy outcomes
Articles by others on the same topic
There are currently no matching articles.